AGP Executive Report
Last update: 2 hours agoDrug Pricing: PhRMA sued the Trump administration to block a Medicare Part B model that would tie some drug prices to those paid abroad, arguing CMS overstepped its authority. Pharma Oversight: India’s Supreme Court directed the government to form a panel on drugmakers’ marketing practices, including freebies to doctors. Gene Therapy: Editas received Australian clearance for the first human trial of a gene-editing treatment for inherited high cholesterol; initial safety data are expected in 2027. Newborn Care: Ukrainian medics visited a Dutch hospital to learn about intensive care for premature babies, including a model that brings parents into daily care and medical rounds. Coverage: Medicaid changes that took effect in Nebraska are expected to affect about 1,000 people, including refugees and asylum-seekers; advocates warn that losing coverage could delay preventive care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
